Insider Transactions in Q1 2022 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,539
-2.1%
|
$50,539
$1.46 P/Share
|
|
Mar 23
2022
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,178
-3.12%
|
$37,178
$1.46 P/Share
|
|
Mar 07
2022
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+8.47%
|
-
|
|
Mar 07
2022
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+11.07%
|
-
|
|
Mar 07
2022
|
Martha J Demski |
BUY
Grant, award, or other acquisition
|
Indirect |
26,586
+46.34%
|
-
|
|
Mar 07
2022
|
Brian Lenz EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
137,500
+10.35%
|
-
|
|
Mar 07
2022
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+43.82%
|
-
|
|
Mar 07
2022
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+20.35%
|
-
|
|
Mar 07
2022
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+50.0%
|
-
|
|
Mar 07
2022
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+10.5%
|
-
|